Moderna and Pfizer's COVID-19 vaccines have shown 90% efficacy during first interim trials and are in the process of getting approval from the FDA.
Pfizer has already submitted the request to FDA for emergency use authorization (EUA). The approval would allow the companies to distribute the vaccine immediately during the pandemic. In contrast, Moderna has said it will gather safety data before submitting the request, which may happen in the coming weeks. Further, the U.S. FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec 10 to take a call on the same after discussing with the scientific and public health experts.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.